Evidence map›Paper›PMID 35008195›Full record

ArticleCancers2021

Aerobic Exercise Training and In Vivo Akt Activation Counteract Cancer Cachexia by Inducing a Hypertrophic Profile through eIF-2α Modulation.

Marcelo G Pereira, Vanessa A Voltarelli, Gabriel C Tobias, Lara de Souza, Gabriela S Borges, Ailma O Paixão, Ney R de Almeida, Thomas Scott Bowen, Marilene Demasi, Elen H Miyabara and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Marcelo G PereiraSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.
Vanessa A VoltarelliSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.
Gabriel C TobiasSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.ORCID 0000-0001-9488-2566
Lara de SouzaSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.
Gabriela S BorgesSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.ORCID 0000-0002-3951-9235
Ailma O PaixãoSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.ORCID 0000-0003-2805-7319
Ney R de AlmeidaSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.
Thomas Scott BowenLeeds School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.
Marilene DemasiBiochemistry and Biophysics Laboratory, Butantan Institute, Sao Paulo 05503900, Brazil.
Elen H MiyabaraDepartment of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508000, Brazil.
Patricia C BrumSchool of Physical Education and Sport, University of Sao Paulo, Sao Paulo 05508030, Brazil.ORCID 0000-0002-4750-6506
Universidade de São Paulo · BRUniversity of Leeds · GBBeth Israel Deaconess Medical Center · USInstituto Butantan · BR

Funding

National Council for Scientific and Technological Development 407360/2018-2São Paulo Research Foundation 2016/26169-0
6 · The paper itself

Abstract

Cancer cachexia is a multifactorial and devastating syndrome characterized by severe skeletal muscle mass loss and dysfunction. As cachexia still has neither a cure nor an effective treatment, better understanding of skeletal muscle plasticity in the context of cancer is of great importance. Although aerobic exercise training (AET) has been shown as an important complementary therapy for chronic diseases and associated comorbidities, the impact of AET on skeletal muscle mass maintenance during cancer progression has not been well documented yet. Here, we show that previous AET induced a protective mechanism against tumor-induced muscle wasting by modulating the Akt/mTORC1 signaling and eukaryotic initiation factors, specifically eIF2-α. Thereafter, it was determined whether the in vivo Akt activation would induce a hypertrophic profile in cachectic muscles. As observed for the first time, Akt-induced hypertrophy was able and sufficient to either prevent or revert cancer cachexia by modulating both Akt/mTORC1 pathway and the eIF-2α activation, and induced a better muscle functionality. These findings provide evidence that skeletal muscle tissue still preserves hypertrophic potential to be stimulated by either AET or gene therapy to counteract cancer cachexia.

Indexed as

Akt-induced hypertrophyAkt/mTORC1 signalingcancer cachexiaeIF-2αphysical exerciseskeletal muscle plasticitytranslation initiation

Identifiers

PMID35008195
PMCPMC8750332
OpenAlexW4200265358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.